 | Up a level |
Journal Article
Bobylev, I, Joshi, A., Barham, M., Neiss, W. F. and Lehmann, H. C. (2015). CISPLATIN ALTERS TRANSCRIPTION AND TRANSPORT OF MRNA OF THE MITOCHONDRIAL FUSION/FISSION MACHINERY IN PERIPHERAL NERVES. J. Peripher. Nerv. Syst., 20 (2). S. 106 - 107. HOBOKEN: WILEY-BLACKWELL. ISSN 1529-8027
Bobylev, I., Joshi, A., Barham, M., Neiss, W. and Lehmann, H. C. (2015). Cisplatin inhibits the expression and transport of mitochondrial dynamic factors in mice. Eur. J. Neurol., 22. S. 313 - 314. HOBOKEN: WILEY. ISSN 1468-1331
Joshi, A., Bobylev, I. and Lehmann, H. C. (2015). Chronic inflammatory demyelinating polyneuropathy (CIDP) sera reduce the ability of Schwann cells to support axonal regeneration. Eur. J. Neurol., 22. S. 412 - 413. HOBOKEN: WILEY. ISSN 1468-1331
Joshi, A., Ladwig, A., Bobylev, I and Lehmann, H. (2016). INTRA-GANGLIONIC DELIVERY OF NITRIC OXIDE DONOR INDUCES MITOCHONDRIAL DAMAGE AND DISTAL AXONOPATHY. J. Peripher. Nerv. Syst., 21 (3). S. 182 - 183. HOBOKEN: WILEY-BLACKWELL. ISSN 1529-8027
Svacina, M. K. R., Ritter, C., Bobylev, I., Joshi, A., Schneider, T. and Lehmann, H. C. (2016). Cardiac effects of combinational pharmacotherapies including fingolimod and symptomatic MS treatments: a preclinical study. Mult. Scler. J., 22. S. 795 - 797. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Wolf, J., Han, J., Nishio, M., Souquet, P., Paz-Ares, L., De Marinis, F., Seto, T., De Jonge, M., Kim, T. M., Vansteenkiste, J., Tan, D., Garon, E., Groen, H., Hochmair, M., Felip, E., Reguart, N., Thomas, M., Overbeck, T., Ohashi, K., Giovannini, M., Yura, R., Joshi, A., Akimov, M. and Heist, R. (2017). GEOMETRY Mono-1: Phase II, Multicenter Study of MET Inhibitor Capmatinib (INC280) in EGFR Wt, MET-Dysregulated Advanced NSCLC. J. Thorac. Oncol., 12 (11). S. S2399 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
Wolf, J., Han, J., Nishio, M., Souquet, P., Paz-Ares, L., De Marinis, F., Seto, T., De Jonge, M., Kim, T. M., Vansteenkiste, J., Tan, D. S. W., Garon, E. B., Groen, H., Hochmair, M. J., Felip, E., Reguart, N., Thomas, M., Overbeck, T., Ohashi, K., Giovannini, M., Yura, R., Joshi, A., Akimov, M. and Heist, R. (2017). GEOMETRY Mono-1: Phase II, Multicenter Study of MET Inhibitor Capmatinib (INC280) in EGFR wt, MET-dysregulated Advanced NSCLC. J. Thorac. Oncol., 12 (11). S. S1578 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
Wolf, J., Neal, J. W., Mansfield, A. S., Doban, V., Kanakamedala, H., Wu, W-H., Joshi, A., de Jong, E., Giovannini, M. and Baik, C. S. (2020). Comparison of clinical outcomes of patients with METDex14 NSCLC treated with first-line capmatinib in the GEOMETRY mono-1 study with those of a cohort of real-world patients. Ann. Oncol., 31. S. S863 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041